Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Marotta

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Transplantation Proceedings|January 3, 2001
Hepatitis C infection is not associated with an increased risk of acute liver allograft rejectionK McLaughlin, K S Rizkalla, P C Adams, et al.
Transplantation|October 6, 1997
Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantationI W Graziadei, R H Wiesner, P J Marotta, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 26, 2009
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapyE M Yoshida, M Sherman, V G Bain, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitisI W Graziadei, R H Wiesner, P J Marotta, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Recurrence of primary sclerosing cholangitis following liver transplantationI W Graziadei, R H Wiesner, K P Batts, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Transplantation Proceedings|January 3, 2001
Hepatitis C infection is not associated with an increased risk of acute liver allograft rejectionK McLaughlin, K S Rizkalla, P C Adams, et al.
Transplantation|October 6, 1997
Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantationI W Graziadei, R H Wiesner, P J Marotta, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 26, 2009
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapyE M Yoshida, M Sherman, V G Bain, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitisI W Graziadei, R H Wiesner, P J Marotta, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Recurrence of primary sclerosing cholangitis following liver transplantationI W Graziadei, R H Wiesner, K P Batts, et al.
Pageof 2